Clinical trial
Combination Chemotherapy in Treating Women With Breast Cancer
NCT00047099
Study timeline
Study start (unknown)2001-08-01Date precision: month
Registry last updated2013-05-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
docetaxelDRUG · verified · RxNorm: docetaxel
epirubicin hydrochlorideDRUG · verified · RxNorm: epirubicin hydrochloride
fluorouracilDRUG · verified · RxNorm: fluorouracil
goserelin acetateDRUG · verified · RxNorm: goserelin acetate
tamoxifen citrateDRUG · verified · RxNorm: tamoxifen citrate
adjuvant therapyPROCEDURE
radiation therapyRADIATION
Sponsors & collaborators
Ludwig-Maximilians - University of Munichlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00047099 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.